Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Axonal Loss in a Rat Model of Optic Neuritis Is Closely Correlated with Visual Evoked Potential Amplitudes Using Electroencephalogram-based Scaling.
Validity and variability of the 5-repetition sit-to-stand test in patients with multiple sclerosis.
IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease.
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.
Amelioration of experimental autoimmune encephalomyelitis by anatabine.
Pain and multiple sclerosis: pathophysiology and treatment.
Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore.
Proteomic analysis of the anti-inflammatory action of minocycline.
[Central motor pathways in children with multiple sclerosis].
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies
The role of interleukin-6 signaling in nervous tissue.
Age-Dependent Seroprevalence of JCV Antibody in Children.
Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses.
Polyunsaturated fatty acids in multiple sclerosis therapy.
Natalizumab treatment reduces endothelial activity in MS patients.
Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis.
Default network activity is a sensitive and specific biomarker of memory in multiple sclerosis.
Structural mechanism for statin inhibition of HMG-CoA reductase.
Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis.
Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials.
What to expect after natalizumab cessation in a real-life setting.
Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.
[Chronically Ill and Unemployed? A Review on Vocational Status in Multiple Sclerosis].
Low-Voltage-Activated CaV3.1 Calcium Channels Shape T Helper Cell Cytokine Profiles.
Multiple sclerosis and pregnancy: maternal considerations.
Pages
« first
‹ previous
…
164
165
166
167
168
169
170
171
172
…
next ›
last »